The latest closing stock price for TransCode Therapeutics as of September 18, 2024 is 0.35.
An investor who bought $1,000 worth of TransCode Therapeutics stock at the IPO in 2021 would have $-934 today, roughly -1 times their original investment - a -59.55% compound annual growth rate over 3 years.
The all-time high TransCode Therapeutics stock closing price was 6.45 on July 12, 2021.
The TransCode Therapeutics 52-week high stock price is 4.63, which is 1222.9% above the current share price.
The TransCode Therapeutics 52-week low stock price is 0.12, which is 65.7% below the current share price.
The average TransCode Therapeutics stock price for the last 52 weeks is 0.61.
An investor who bought $1,000 worth of TransCode Therapeutics stock at the IPO in 2021 would have $-934 today, roughly -1 times their original investment - a -59.55% compound annual growth rate over 3 years.
The all-time high TransCode Therapeutics stock closing price was 6.45 on July 12, 2021.
The TransCode Therapeutics 52-week high stock price is 4.63, which is 1222.9% above the current share price.
The TransCode Therapeutics 52-week low stock price is 0.12, which is 65.7% below the current share price.
The average TransCode Therapeutics stock price for the last 52 weeks is 0.61.